Atypical Protein Kinase C ι Protects Human Leukemia Cells against Drug-induced Apoptosis
Open Access
- 1 October 1997
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 272 (44), 27521-27524
- https://doi.org/10.1074/jbc.272.44.27521
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Interaction of protein kinase C ζ with ZIP, a novel protein kinase C-binding proteinProceedings of the National Academy of Sciences of the United States of America, 1997
- Ultraviolet B-induced Activated Protein-1 Activation Does Not Require Epidermal Growth Factor Receptor but Is Blocked by a Dominant Negative PKCλ/ιPublished by Elsevier BV ,1996
- Cross-talk between Different Enhancer Elements during Mitogenic Induction of the Human Stromelysin-1 GenePublished by Elsevier BV ,1996
- βII Protein Kinase C Is Required for the G2/M Phase Transition of Cell CyclePublished by Elsevier BV ,1996
- Activation of protein kinase C isozymes is associated with post-mitotic events in intestinal epithelial cells in situ.The Journal of cell biology, 1994
- 1-?-d-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentationCancer Chemotherapy and Pharmacology, 1994
- Tissue and cellular distribution of the extended family of protein kinase C isoenzymesThe Journal of cell biology, 1992
- The molecular heterogeneity of protein kinase C and its implications for cellular regulationNature, 1988
- Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiation.Proceedings of the National Academy of Sciences of the United States of America, 1987
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980